Centene Corp Announces Executive and Director Changes

Ticker: CNC · Form: 8-K · Filed: 2024-09-27T00:00:00.000Z

Sentiment: neutral

Topics: management-change, governance

Related Tickers: CNC

TL;DR

Centene's board and exec team are shuffling; new faces and comp changes announced.

AI Summary

Centene Corporation announced on September 25, 2024, changes in its executive and director roles. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. Specific names and dollar amounts related to these changes were not detailed in the provided excerpt.

Why It Matters

Changes in executive and director leadership can signal shifts in company strategy, governance, or operational focus, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Executive and director changes can introduce uncertainty regarding future strategy and leadership stability.

Key Players & Entities

FAQ

What specific roles have seen departures or appointments?

The filing indicates departures of certain officers and directors, the election of new directors, and changes to compensatory arrangements for certain officers, but specific role titles are not detailed in the excerpt.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on September 25, 2024.

What is Centene Corporation's state of incorporation?

Centene Corporation is incorporated in Delaware.

What is Centene Corporation's IRS Employer Identification Number?

Centene Corporation's IRS Employer Identification Number is 42-1406317.

What is the SIC code for Centene Corporation?

The Standard Industrial Classification (SIC) code for Centene Corporation is 6324, which corresponds to Hospital & Medical Service Plans.

From the Filing

0001071739-24-000175.txt : 20240927 0001071739-24-000175.hdr.sgml : 20240927 20240927164409 ACCESSION NUMBER: 0001071739-24-000175 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240925 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240927 DATE AS OF CHANGE: 20240927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 241335566 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20240925.htm 8-K cnc-20240925 0001071739 false 0001071739 2024-09-25 2024-09-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS (b) On September 25, 2024, Director Lori J. Robinson notified Centene Corporation (the “Company”) of her decision not to stand for re-election when her term expires at the Company’s 2025 Annual Meeting. The Company greatly appreciates Director Robinson’s five years of service, leadership and contributions to the Board. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CENTENE CORPORATION Date: September 27, 2024 By: /s/

View on Read The Filing